IDEXX Laboratories, Inc. Share Price
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
12:53:12 15/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 526.80 USD | +1.25% |
|
+3.84% | -22.23% |
| 12/10 | KeyBanc Initiates IDEXX Laboratories at Sector Weight | MT |
| 01/10 | IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI | MT |
| Market Cap | 4.1TCr 3.69TCr 3.44TCr 3.12TCr 5.85TCr 3,90100Cr 5.89TCr 41TCr 16TCr 2,02500Cr 15TCr 15TCr 6,51100Cr | P/E 2026 * |
35.2x | P/E 2027 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.14TCr 3.72TCr 3.47TCr 3.15TCr 5.9TCr 3,93600Cr 5.94TCr 42TCr 16TCr 2,04300Cr 16TCr 15TCr 6,57000Cr | EV / Sales 2026 * |
8.76x | EV / Sales 2027 * | 7.96x |
| Free-Float |
72.37% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IDXX | Delayed | |
CBOE
| IDXX | Real-time | |
|
Mexican S.E.
| IDXX * | End-of-day quote | |
|
London S.E.
| 0J8P | Delayed | |
|
Xetra
| IX1 | Delayed | |
|
Tradegate
| IX1 | Real-time | |
|
Boerse Muenchen
| IX1 | Real-time | |
|
Deutsche Boerse AG
| IX1 | Delayed | |
|
Wiener Boerse
| IDXX | End-of-day quote | |
|
Börse Stuttgart
| IX1 | Delayed | |
|
Berne S.E.
| IX1 | End-of-day quote | |
|
Borsa Italiana
| 1IDXX | End-of-day quote |
Last Transcript: IDEXX Laboratories, Inc.
| 1 day | +1.26% | ||
| 1 week | +3.84% | ||
| Current month | +0.75% | ||
| 1 month | +3.25% | ||
| 3 months | -2.69% | ||
| 6 months | -9.92% | ||
| Current year | -22.23% |
| 1 week | 506.12 |  | 529.52 |
| 1 month | 501.17 | | 536.84 |
| Current year | 500.61 | | 726.41 |
| 1 year | 500.61 | | 769.98 |
| 3 years | 356.14 | | 769.98 |
| 5 years | 317.06 | | 769.98 |
| 10 years | 102.45 | | 769.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Erickson
CEO | Chief Executive Officer | 52 | 12/05/2026 |
Andrew Emerson
DFI | Director of Finance/CFO | 43 | 01/03/2025 |
Martin Smith
COO | Chief Operating Officer | 58 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 12/05/2026 | |
| Director/Board Member | 64 | 15/07/2013 | |
Daniel Junius
BRD | Director/Board Member | 73 | 11/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/26 | Exercice | Director | 6,609 | 0.0084% | ||
| 20/08/26 | Exercice | Chief Financial Officer | 616 | 0.0008% | ||
| 30/07/26 | Free | Director | 49 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | +3.84% | -17.39% | +22.48% | 4.1TCr | |
| +0.08% | +4.01% | -22.95% | +11.40% | 18TCr | |
| +0.87% | +9.33% | -3.16% | +30.30% | 12TCr | |
| -0.16% | +2.19% | -23.94% | +6.57% | 11TCr | |
| +1.23% | +0.99% | -45.59% | -10.58% | 7.53TCr | |
| +1.51% | +5.64% | +5.42% | +79.36% | 6.3TCr | |
| +0.34% | +0.40% | +16.65% | +62.51% | 5.35TCr | |
| +0.29% | +4.37% | -0.18% | -27.61% | 5.1TCr | |
| -1.55% | -0.63% | +26.52% | +6.11% | 3.21TCr | |
| +0.08% | +0.68% | - | - | 3.13TCr | |
| Average | +0.39% | +2.32% | -7.18% | +20.06% | 7.52TCr | |
| Weighted average by Cap. | +0.43% | +3.04% | -12.65% | +18.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 472.2Cr 424.55Cr 396.2Cr 359.08Cr 674.17Cr 45TCr 678.36Cr 4.75TCr 1.86TCr 23TCr 1.77TCr 1.73TCr 75TCr | 513.92Cr 462.06Cr 431.2Cr 390.81Cr 733.73Cr 49TCr 738.29Cr 5.17TCr 2.02TCr 25TCr 1.93TCr 1.89TCr 82TCr |
| Net income | 117.82Cr 105.94Cr 99Cr 90Cr 168.22Cr 11TCr 169.27Cr 1.19TCr 463.26Cr 5.82TCr 442.36Cr 432.78Cr 19TCr | 131.3Cr 118.05Cr 110.17Cr 100Cr 187.46Cr 12TCr 188.63Cr 1.32TCr 516.26Cr 6.49TCr 492.96Cr 482.29Cr 21TCr |
| Net Debt | 37Cr 33Cr 31Cr 28Cr 53Cr 3.5TCr 53Cr 370.55Cr 144.69Cr 1.82TCr 138.16Cr 135.17Cr 5.85TCr | -9.73Cr -8.75Cr -8.17Cr -7.4Cr -14Cr -926.31Cr -14Cr -98Cr -38Cr -480.76Cr -37Cr -36Cr -1.55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | $526.75 | +1.24% | 4,83,078 |
| 13/26/13 | $520.31 | -0.69% | 4,45,415 |
| 12/26/12 | $523.94 | +1.15% | 5,52,787 |
| 09/26/09 | $518.00 | +0.95% | 4,66,778 |
| 08/26/08 | $513.14 | +1.28% | 6,96,677 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IDXX Stock
Select your edition
All financial news and data tailored to specific country editions
